Rheumatoid Arthritis
Showing NaN - NaN of 106
Rheumatoid Arthritis Trial in Worldwide (VX-509, VX-509 matching )
Completed
- Rheumatoid Arthritis
- VX-509
- VX-509 matching placebo
-
Birmingham, Alabama
- +93 more
Oct 23, 2015
Rheumatoid Arthritis Trial in Worldwide (Tocilizumab 162 mg, Placebo)
Completed
- Rheumatoid Arthritis
- Tocilizumab 162 mg
- Placebo
-
Peoria, Arizona
- +140 more
Jul 7, 2015
Rheumatoid Arthritis Trial in Worldwide (Abatacept (ABA) + Methotrexate (MTX), double-blind (DB), Infliximab (INF) + MTX, DB,
Completed
- Rheumatoid Arthritis
- Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)
- +4 more
-
Huntsville, Alabama
- +75 more
Mar 4, 2015
Rheumatoid Arthritis Trial in Poland, United States (INCB018424, Placebo)
Rheumatoid Arthritis Trial in Worldwide (secukinumab (AIN457), )
Completed
- Rheumatoid Arthritis
- secukinumab (AIN457)
- placebo
-
Vestavia, Alabama
- +38 more
Feb 12, 2015
Active Rheumatoid Arthritis, Arthritis, Rheumatoid, Rheumatoid Arthritis Trial in Worldwide (etanercept)
Completed
- Active Rheumatoid Arthritis
- +2 more
-
Lyon, France
- +57 more
Jul 15, 2014
Rheumatoid Arthritis Trial in Worldwide (RWJ-445380 100 mg, RWJ-445380 200 mg, RWJ-445380 300 mg)
Completed
- Rheumatoid Arthritis
- RWJ-445380 100 mg
- +3 more
-
Birmingham, Alabama
- +43 more
May 6, 2014
Rheumatoid Arthritis Trial in Worldwide (Fostamatinib and injections, Adalimumab and of fostamatinib, Placebo of fostamatinib,
Terminated
- Rheumatoid Arthritis
- Fostamatinib and placebo injections
- +2 more
-
Birmingham, Alabama
- +108 more
Apr 3, 2014
Rheumatoid Arthritis Trial in Worldwide (CRx-102 (2.7/180), prednisolone, dipyridamole)
Completed
- Rheumatoid Arthritis
- CRx-102 (2.7/180)
- +4 more
-
Birmingham, Alabama
- +47 more
Mar 27, 2014
Rheumatoid Arthritis Trial in Worldwide (fostamatinib, , fostamatinib)
Completed
- Rheumatoid Arthritis
- fostamatinib
- placebo, fostamatinib
-
Anniston, Alabama
- +126 more
Feb 27, 2014
Rheumatoid Arthritis Trial in Worldwide (Placebo, Certolizumab Pegol (CZP) 200 mg, Certolizumab Pegol (CZP) 400 mg)
Completed
- Rheumatoid Arthritis
- Placebo
- +2 more
-
Frederiksberg, Denmark
- +9 more
Feb 7, 2014
Rheumatoid Arthritis Trial in Worldwide (tocilizumab [RoActemra/Actemra], Placebo, Methotrexate)
Completed
- Rheumatoid Arthritis
- tocilizumab [RoActemra/Actemra]
- +2 more
-
Birmingham, Alabama
- +151 more
Dec 18, 2013
Rheumatoid Arthritis Trial in Worldwide (BG00012, )
Completed
- Rheumatoid Arthritis
- BG00012
- placebo
-
Woolloongabba, Queensland, Australia
- +24 more
Sep 12, 2013
Rheumatoid Arthritis Trial in Worldwide (MR prednisone, Placebo)
Completed
- Rheumatoid Arthritis
- MR prednisone
- Placebo
-
Huntsville, Alabama
- +51 more
Apr 23, 2013
Rheumatoid Arthritis Trial in Poland, United States (CP-690,550, )
Rheumatoid Arthritis Trial in Worldwide (drug, other, biological)
Completed
- Rheumatoid Arthritis
- CP 690,550
- +3 more
-
Gilbert, Arizona
- +124 more
Jan 10, 2013
Rheumatoid Arthritis Trial in Worldwide (Revamilast, Placebo Comparator)
Completed
- Rheumatoid Arthritis
- Revamilast
- Placebo Comparator
-
Hyderabad, Andhra Pradesh, India
- +35 more
Dec 27, 2012
Rheumatoid Arthritis Trial in Worldwide (SC12267 (4SC-101), Placebo, Methotrexate)
Completed
- Rheumatoid Arthritis
- SC12267 (4SC-101)
- +3 more
-
Plovdiv, Bulgaria
- +26 more
Feb 29, 2012
Rheumatoid Arthritis Trial in Worldwide (LX3305 low dose, LX3305 mid dose, LX3305 high dose)
Completed
- Rheumatoid Arthritis
- LX3305 low dose
- +3 more
-
Gainesville, Florida
- +37 more
Nov 11, 2011